Our study shows that in the presence of SF3B1 and SRSF2 mutations, none of the DNMT3A mutant MDS cases had AML transformation, suggesting these mutations are disease and phenotype-defining in the context of DNMT3A R882 mutations. The gene discussed is SRSF2; the disease is acute myeloid leukemia.